Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Building Materials

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

Revenue projections:

Revenue projections for AMBUJACEM
Revenue projections for AMBUJACEM

Ambuja Cements Limited's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.000000
forwardPE 28.808289
debtToEquity 1.829000
earningsGrowth -0.905000
revenueGrowth 0.102000
grossMargins 0.572630
operatingMargins 0.038340
trailingEps 14.960000
forwardEps 17.370000

With AMBUJACEM's Forward PE in a favorable range, the stock appears reasonably priced compared to its earnings. This suggests that it's not overpriced and there is room for growth, providing an encouraging opportunity for investors seeking future value increases.
Ambuja Cements Limited's low earnings and revenue growth suggest that the company's profits may shrink. This trend could indicate underlying financial struggles and pose challenges for Ambuja Cements Limited's future profitability.
AMBUJACEM's negative gross and operating margins suggest the company is not generating profit from either its production process or day-to-day operations. This could signal cost overruns or difficulties in maintaining revenue levels.
AMBUJACEM's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that AMBUJACEM is likely to outperform its previous year's financial performance.

Price projections:

Price projections for AMBUJACEM
Price projections for AMBUJACEM

Price projections for AMBUJACEM have been revised down over time, reflecting a less optimistic outlook. Analysts appear to be adjusting their expectations, signaling concerns about the company's ability to sustain its previous growth levels.

Recommendation changes over time:

Recommendations trend for AMBUJACEM
Recommendations trend for AMBUJACEM


A recent buy bias from analysts toward AMBUJACEM indicates strong confidence in the stock's future performance. This could encourage investors to park their money in AMBUJACEM, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.